ERIC RACHAL: Open Payments
NPI 1538866793 · LAKE CHARLES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,252 in 208 payments from 16 companies in 2025. Trend: 2023 $2,424 · 2024 $3,361 · 2025 $3,252
Food & beverage: $3,240Education: $12
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $577 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 26 | $475 |
| Otsuka America Pharmaceutical, Inc. | 25 | $370 |
| Alkermes, Inc. | 20 | $258 |
| Neurocrine BioSciences, Inc. | 13 | $227 |
| Teva Pharmaceuticals USA, Inc. | 18 | $220 |
| Corium, LLC | 12 | $207 |
| Axsome Therapeutics, Inc. | 19 | $203 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $156 |
| Vanda Pharmaceuticals Inc. | 8 | $147 |
Products named: VRAYLAR, CAPLYTA, REXULTI, ARISTADA, INGREZZA, Azstarys, Auvelity, TRINTELLIX.
Industry payments across LA — which companies pay providers there.
